{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:39:56Z","timestamp":1768642796235,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K09677"],"award-info":[{"award-number":["JP20K09677"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K09682"],"award-info":[{"award-number":["JP20K09682"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Human papillomavirus (HPV) type 67 is phylogenetically classified into<jats:italic>Alphapapillomavirus<\/jats:italic>species 9 (alpha-9) together with other carcinogenic types (HPV16, 31, 33, 35, 52 and 58), but is the only alpha-9 type defined as possibly carcinogenic. This study aimed to determine whole-genome sequences of HPV67 isolated from Japanese women with cervical cancer or cervical intraepithelial neoplasia (CIN) to better understand the genetic basis of the\u00a0oncogenic potential of HPV67.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Total cellular DNA isolated from cervical exfoliated cells that were single positive for HPV67 (invasive cervical cancer, n\u2009=\u20092; CIN3, n\u2009=\u20096; CIN 2, n\u2009=\u20091; CIN1, n\u2009=\u20092; the normal cervix, n\u2009=\u20091) was subjected to PCR to amplify HPV67 DNA, followed by next generation sequencing to determine the complete viral genome sequences. Variant lineages\/sublineages were assigned through viral whole-genome phylogenetic analysis. The transcriptional activity of the virus early promoter was assessed by luciferase reporter assays in cervical cancer cell lines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Phylogenetic analyses of HPV67 genomes from Japan (n\u2009=\u200912) revealed that 11 belonged to lineage A (sublineage A1, n\u2009=\u20099; sublineage A2, n\u2009=\u20092) and one belonged to lineage B. All cancer cases contained sublineage A1 variants, and one of these contained an in-frame deletion in the<jats:italic>E2<\/jats:italic>gene. The long control region of the HPV67 genome did not induce transcription from the virus early promoter in HeLa cells, but showed weak transcriptional activity in CaSki cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The single detection of HPV67 in cervical cancer and precancer specimens strongly suggests the carcinogenic potential of this rare genotype. The phylogenetic analysis indicates a predominance of lineage A variants among HPV67 infections in Japan. Since only 23 complete genome sequences of HPV67 had been obtained until now, the newly determined genome sequences in this study are expected to contribute to further functional and evolutionary studies on the genetic diversity of HPV67.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12985-022-01894-z","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T17:06:57Z","timestamp":1665162417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Whole-genome analysis of human papillomavirus 67 isolated from Japanese women with cervical lesions"],"prefix":"10.1186","volume":"19","author":[{"given":"Gota","family":"Kogure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Onuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Yamaguchi-Naka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Sekizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Kukimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"1894_CR1","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","volume":"2","author":"M Schiffman","year":"2016","unstructured":"Schiffman M, Doorbar J, Wentzensen N, de Sanjose S, Fakhry C, Monk BJ, Stanley MA, Franceschi S. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016;2:16086.","journal-title":"Nat Rev Dis Primers"},{"key":"1894_CR2","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048\u201356.","journal-title":"Lancet Oncol"},{"key":"1894_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/path.4424","volume":"234","author":"M Arbyn","year":"2014","unstructured":"Arbyn M, Tommasino M, Depuydt C, Dillner J. Are 20 human papillomavirus types causing cervical cancer? J Pathol. 2014;234:431\u20135.","journal-title":"J Pathol"},{"key":"1894_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<412::AID-IJC7>3.0.CO;2-S","volume":"72","author":"M Sugase","year":"1997","unstructured":"Sugase M, Matsukura T. Distinct manifestations of human papillomaviruses in the vagina. Int J Cancer. 1997;72:412\u20135.","journal-title":"Int J Cancer"},{"key":"1894_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/path.4065","volume":"228","author":"D Geraets","year":"2012","unstructured":"Geraets D, Alemany L, Guimera N, de Sanjose S, de Koning M, Molijn A, Jenkins D, Bosch X, Quint W, RIS HPV TT Study Group. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer. J Pathol. 2012;228:534\u201343.","journal-title":"J Pathol"},{"key":"1894_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ijc.25396","volume":"128","author":"N Li","year":"2011","unstructured":"Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128:927\u201335.","journal-title":"Int J Cancer"},{"key":"1894_CR7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ijc.29019","volume":"136","author":"JD Combes","year":"2015","unstructured":"Combes JD, Guan P, Franceschi S, Clifford GM. Judging the carcinogenicity of rare human papillomavirus types. Int J Cancer. 2015;136:740\u20132.","journal-title":"Int J Cancer"},{"key":"1894_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pvr.2018.10.001","volume":"6","author":"J Sakamoto","year":"2018","unstructured":"Sakamoto J, Kamiura S, Okayama K, Okodo M, Shibata T, Osaka Y, Fujita S, Takata E, Takagi H, Takakura M, Sasagawa T. Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan. Papillomavirus Res. 2018;6:46\u201351.","journal-title":"Papillomavirus Res"},{"key":"1894_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020183","volume":"6","author":"Z Chen","year":"2011","unstructured":"Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS ONE. 2011;6: e20183.","journal-title":"PLoS ONE"},{"key":"1894_CR10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/jjco\/hyu112","volume":"44","author":"Y Azuma","year":"2014","unstructured":"Azuma Y, Kusumoto-Matsuo R, Takeuchi F, Uenoyama A, Kondo K, Tsunoda H, Nagasaka K, Kawana K, Morisada T, Iwata T, et al. Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2\/3 and invasive cervical cancer in Japanese women. Jpn J Clin Oncol. 2014;44:910\u20137.","journal-title":"Jpn J Clin Oncol"},{"key":"1894_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fmicb.2016.00032","volume":"7","author":"A Yamashita","year":"2016","unstructured":"Yamashita A, Sekizuka T, Kuroda M. VirusTAP: viral genome-targeted assembly pipeline. Front Microbiol. 2016;7:32.","journal-title":"Front Microbiol"},{"key":"1894_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.virol.2005.10.025","volume":"346","author":"I Kukimoto","year":"2006","unstructured":"Kukimoto I, Takeuchi T, Kanda T. CCAAT\/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16. Virology. 2006;346:98\u2013107.","journal-title":"Virology"},{"key":"1894_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01945-19","volume":"94","author":"S Mori","year":"2020","unstructured":"Mori S, Takeuchi T, Ishii Y, Kukimoto I. The transcriptional cofactor VGLL1 drives transcription of human papillomavirus early genes via TEAD1. J Virol. 2020;94: e01945-19.","journal-title":"J Virol"},{"key":"1894_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/v9070175","volume":"9","author":"I Martinez-Ramirez","year":"2017","unstructured":"Martinez-Ramirez I, Del-Castillo-Falconi V, Mitre-Aguilar IB, Amador-Molina A, Carrillo-Garcia A, Langley E, Zentella-Dehesa A, Soto-Reyes E, Garcia-Carranca A, Herrera LA, Lizano M. SOX2 as a new regulator of HPV16 transcription. Viruses. 2017;9:175.","journal-title":"Viruses"},{"key":"1894_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1023\/A:1008002905588","volume":"17","author":"Y Kirii","year":"1998","unstructured":"Kirii Y, Matsukura T. Nucleotide sequence and phylogenetic classification of human papillomavirus type 67. Virus Genes. 1998;17:117\u201321.","journal-title":"Virus Genes"},{"key":"1894_CR16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/v12121437","volume":"12","author":"A Latsuzbaia","year":"2020","unstructured":"Latsuzbaia A, Wienecke-Baldacchino A, Tapp J, Arbyn M, Karabegovic I, Chen Z, Fischer M, Muhlschlegel F, Weyers S, Pesch P, Mossong J. Characterization and diversity of 243 complete human papillomavirus genomes in cervical swabs using next generation sequencing. Viruses. 2020;12:1437.","journal-title":"Viruses"},{"key":"1894_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/molbev\/msw214","volume":"34","author":"VN Pimenoff","year":"2017","unstructured":"Pimenoff VN, de Oliveira CM, Bravo IG. Transmission between archaic and modern human ancestors during the evolution of the oncogenic human papillomavirus 16. Mol Biol Evol. 2017;34:4\u201319.","journal-title":"Mol Biol Evol"},{"key":"1894_CR18","doi-asserted-by":"publisher","first-page":"e01285","DOI":"10.1128\/JVI.01285-17","volume":"91","author":"Z Chen","year":"2017","unstructured":"Chen Z, Ho WCS, Boon SS, Law PTY, Chan MCW, DeSalle R, Burk RD, Chan PKS. Ancient evolution and dispersion of human papillomavirus 58 variants. J Virol. 2017;91:e01285-e11217.","journal-title":"J Virol"},{"key":"1894_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/path.4405","volume":"234","author":"G Halec","year":"2014","unstructured":"Halec G, Alemany L, Lloveras B, Schmitt M, Alejo M, Bosch FX, Tous S, Klaustermeier JE, Guimera N, Grabe N, et al. Pathogenic role of the eight probably\/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. J Pathol. 2014;234:441\u201351.","journal-title":"J Pathol"},{"key":"1894_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265996","volume":"17","author":"J Sakamoto","year":"2022","unstructured":"Sakamoto J, Saito M, Zhang S, Takakura M, Takagi H, Sasagawa T. Determination of human papillomavirus type in archival tissue specimens of invasive cervical cancer using molecular mapping and E6\/E7-based polymerase chain reaction. PLoS ONE. 2022;17: e0265996.","journal-title":"PLoS ONE"},{"key":"1894_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature16481","volume":"529","author":"D Martinez-Zapien","year":"2016","unstructured":"Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A, Cousido-Siah A, Masson M, Vande Pol S, Podjarny A, et al. Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53. Nature. 2016;529:541\u20135.","journal-title":"Nature"},{"key":"1894_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0042-6822(02)00012-0","volume":"306","author":"B Cooper","year":"2003","unstructured":"Cooper B, Schneider S, Bohl J, Jiang Y, Beaudet A, Vande Pol S. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology. 2003;306:87\u201399.","journal-title":"Virology"},{"key":"1894_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006211","volume":"13","author":"AA McBride","year":"2017","unstructured":"McBride AA, Warburton A. The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog. 2017;13: e1006211.","journal-title":"PLoS Pathog"},{"key":"1894_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.virol.2013.06.006","volume":"445","author":"AA McBride","year":"2013","unstructured":"McBride AA. The papillomavirus E2 proteins. Virology. 2013;445:57\u201379.","journal-title":"Virology"},{"key":"1894_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cmi.2021.04.031","volume":"27","author":"M Arbyn","year":"2021","unstructured":"Arbyn M, Simon M, Peeters E, Xu L, Meijer C, Berkhof J, Cuschieri K, Bonde J, Ostrbenk Vanlencak A, Zhao FH, et al. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening. Clin Microbiol Infect. 2021;27:1083\u201395.","journal-title":"Clin Microbiol Infect"},{"key":"1894_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/jmv.25017","volume":"90","author":"M Okodo","year":"2018","unstructured":"Okodo M, Okayama K, Teruya K, Sasagawa T. Uniplex E6\/E7 PCR method detecting E6 or E7 genes in 39 human papillomavirus types. J Med Virol. 2018;90:981\u20138.","journal-title":"J Med Virol"},{"key":"1894_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1620\/tjem.251.287","volume":"251","author":"I Kukimoto","year":"2020","unstructured":"Kukimoto I, Matsumoto K, Takahashi F, Iwata T, Tanaka K, Yamaguchi-Naka M, Yamamoto K, Yahata H, Nakabayashi M, Kato H, et al. Human papillomavirus (HPV) genotyping assay suitable for monitoring the impact of the 9-valent HPV vaccine. Tohoku J Exp Med. 2020;251:287\u201394.","journal-title":"Tohoku J Exp Med"},{"key":"1894_CR28","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/cancers14030652","volume":"14","author":"K Andersen","year":"2022","unstructured":"Andersen K, Holm K, Tranberg M, Pedersen CL, Bonlokke S, Steiniche T, Andersen B, Stougaard M. Targeted next generation sequencing for human papillomavirus genotyping in cervical liquid-based cytology samples. Cancers (Basel). 2022;14:652.","journal-title":"Cancers (Basel)"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01894-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-022-01894-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01894-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T16:15:00Z","timestamp":1701188100000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-022-01894-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1894"],"URL":"https:\/\/doi.org\/10.1186\/s12985-022-01894-z","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committees at each hospital and the National Institute of Infectious Diseases, and written informed consent for study participation was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}